Advertisement

Journal of Molecular Neuroscience

, Volume 57, Issue 2, pp 176–184 | Cite as

Involvement of MeCP2 in Regulation of Myelin-Related Gene Expression in Cultured Rat Oligodendrocytes

  • Kedarlal Sharma
  • Juhi Singh
  • Prakash P. PillaiEmail author
  • Emma E. Frost
Article

Abstract

Methyl CpG binding protein 2 (MeCP2) is a multifunctional protein which binds to methylated CpG, mutation of which cause a neurodevelopmental disorder, Rett syndrome. MeCP2 can function as both transcriptional activator and repressor of target gene. MeCP2 regulate gene expression in both neuron and glial cells in central nervous system (CNS). Oligodendrocytes, the myelinating cells of CNS, are required for normal functioning of neurons and are regulated by several transcription factors during their differentiation. In current study, we focused on the role of MeCP2 as transcription regulator of myelin genes in cultured rat oligodendrocytes. We have observed expression of MeCP2 at all stages of oligodendrocyte development. MeCP2 knockdown in cultured oligodendrocytes by small interference RNA (siRNA) has shown increase in myelin genes (myelin basic protein (MBP), proteolipid protein (PLP), myelin oligodendrocyte glycoprotein (MOG), and myelin-associated oligodendrocyte basic protein (MOBP)), neurotrophin (brain-derived neurotrophic factor (BDNF)), and transcriptional regulator (YY1) transcripts level, which are involved in regulation of oligodendrocyte differentiation and myelination. Further, we also found that protein levels of MBP, PLP, DM-20, and BDNF also significantly upregulated in MeCP2 knockdown oligodendrocytes. Our study suggests that the MeCP2 acts as a negative regulator of myelin protein expression.

Keywords

MeCP2 Myelination Rett syndrome Oligodendrocytes MBP PLP MOG MOBP BDNF YY1 

Notes

Acknowledgments

This work was supported by grants from the Department of Biotechnology (DBT), New Delhi, India, (sanction order no. BT/PR4974/MED/30/773/2012 dated 10/09/2013). We thank the Department of Biotechnology (DBT), New Delhi, India, and University Grants Commission (UGC), New Delhi, India (UGC reference no. and date- F. no. 41-148/2012 (SR) dated 13/07/2012) for awarding Junior Research Fellows (JRFs) to Kedarlal Sharma and Juhi Singh, respectively. We are also very much thankful to DBT-ILSPARE Programme, for providing us the Confocal microscopy and Real-Time PCR facility in Dr. Vikram Sarabhai Science Block, Faculty of Science, MSU, Baroda.

Conflict of Interest

The authors declare that they have no conflict of interest.

References

  1. Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY (1999) Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 23(2):185–188CrossRefPubMedGoogle Scholar
  2. Ballas N, Lioy D, Grunseich C, Mandel G (2009) Non–cell autonomous influence of MeCP2-deficient glia on neuronal dendritic morphology. Nat Neurosci 12(3):311–317CrossRefPubMedPubMedCentralGoogle Scholar
  3. Baumann N, Pham-Dinh D (2001) Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiol Rev 81(2):871–927PubMedGoogle Scholar
  4. Ben-Shachar S, Chahrour M, Thaller C, Shaw CA, Zoghbi HY (2009) Mouse models of MeCP2 disorders share gene expression changes in the cerebellum and hypothalamus. Hum Mol Genet 18(13):2431–2442CrossRefPubMedPubMedCentralGoogle Scholar
  5. Bottenstein JE, Sato GH (1979) Growth of a rat neuroblastoma cell line in serum-free supplemented medium. Proc Natl Acad Sci 76(1):514–517CrossRefPubMedPubMedCentralGoogle Scholar
  6. Bradl M, Lassmann H (2010) Oligodendrocytes: biology and pathology. Acta Neuropathol 119(1):37–53CrossRefPubMedGoogle Scholar
  7. Chahrour M, Jung S, Shaw C, Zhou X, Wong STC, Qin J, Zoghbi HY (2008) MeCP2, a key contributor to neurological disease, activates and represses transcription. Science (New York, NY) 320(5880):1224–1229CrossRefGoogle Scholar
  8. Chen Y, Balasubramaniyan V, Peng J, Hurlock EC, Tallquist M, Li J, Lu QR (2007) Isolation and culture of rat and mouse oligodendrocyte precursor cells. Nat Protoc 2(5):1044–1051CrossRefPubMedGoogle Scholar
  9. Dai X, Lercher LD, Clinton PM, Du Y, Livingston DL, Vieira C, Dreyfus CF (2003) The trophic role of oligodendrocytes in the basal forebrain. J Neurosci 23(13):5846–5853PubMedGoogle Scholar
  10. DeWald LE, Rodriguez JP, Levine JM (2011) The RE1 binding protein REST regulates oligodendrocyte differentiation. J Neurosci 31(9):3470–3483CrossRefPubMedGoogle Scholar
  11. Emery B (2010a) Regulation of oligodendrocyte differentiation and myelination. Science 330(6005):779–782CrossRefPubMedGoogle Scholar
  12. Emery B (2010b) Transcriptional and post-transcriptional control of CNS myelination. Curr Opin Neurobiol 20(5):601–607CrossRefPubMedGoogle Scholar
  13. Fuchikami M, Morinobu S, Kurata A, Yamamoto S, Yamawaki S (2009) Single immobilization stress differentially alters the expression profile of transcripts of the brain-derived neurotrophic factor (BDNF) gene and histone acetylation at its promoters in the rat hippocampus. Int J Neuropsychopharmacol 12(1):73–82CrossRefPubMedGoogle Scholar
  14. Fulton D, Paez PM, Campagnoni AT (2009) The multiple roles of myelin protein genes during the development of the oligodendrocyte. ASN Neuro 2(1), AN20090051Google Scholar
  15. Ghiani CA, Ying Z, Vellis JD, Gomez‐Pinilla F (2007) Exercise decreases myelin‐associated glycoprotein expression in the spinal cord and positively modulates neuronal growth. Glia 55(9):966–975CrossRefPubMedPubMedCentralGoogle Scholar
  16. Guy J, Cheval H, Selfridge J, Bird A (2011) The role of MeCP2 in the brain. Annu Rev Cell Dev Biol 27:631–652CrossRefPubMedGoogle Scholar
  17. He L, Lu QR (2013) Coordinated control of oligodendrocyte development by extrinsic and intrinsic signaling cues. Neurosci Bull 29(2):129–143CrossRefPubMedPubMedCentralGoogle Scholar
  18. He Y, Dupree J, Wang J, Sandoval J, Li J, Liu H, Casaccia-Bonnefil P (2007) The transcription factor Yin Yang 1 is essential for oligodendrocyte progenitor differentiation. Neuron 55(2):217–230CrossRefPubMedPubMedCentralGoogle Scholar
  19. Huang H, Zhao XF, Zheng K, Qiu M (2013) Regulation of the timing of oligodendrocyte differentiation: mechanisms and perspectives. Neurosci Bull 29(2):155–164CrossRefPubMedPubMedCentralGoogle Scholar
  20. Jung BP, Jugloff DGM, Zhang G, Logan R, Brown S, Eubanks JH (2003) The expression of methyl CpG binding factor MeCP2 correlates with cellular differentiation in the developing rat brain and in cultured cells ABSTRACT. J Neurobiol 55(1):86–96Google Scholar
  21. Khorshid Ahmad, T., Acosta, C., Cortes, C., Lakowski, T. M., Gangadaran, S., & Namaka, M. (2015). Transcriptional Regulation of Brain-Derived Neurotrophic Factor (BDNF) by Methyl CpG Binding Protein 2 (MeCP2): a Novel Mechanism for Re-Myelination and/or Myelin Repair Involved in the Treatment of Multiple Sclerosis (MS). Molecular neurobiology, 1-16Google Scholar
  22. Kishi N, Macklis J (2004) MECP2 is progressively expressed in post-migratory neurons and is involved in neuronal maturation rather than cell fate decisions. Mol Cell Neurosci 27(3):306–321Google Scholar
  23. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2− ΔΔCT method. Methods 25(4):402–408CrossRefPubMedGoogle Scholar
  24. Maezawa I, Jin LW (2010) Rett syndrome microglia damage dendrites and synapses by the elevated release of glutamate. J Neurosci 30(15):5346–5356CrossRefPubMedGoogle Scholar
  25. Matsuoka T, Tsunoda M, Sumiyoshi T, Takasaki I, Tabuchi Y, Seo T, Kurachi M (2008) Effect of MK‐801 on gene expressions in the amygdala of rats. Synapse 62(1):1–7CrossRefPubMedGoogle Scholar
  26. Meehan R, Lewis JD, Bird AP (1992) Characterization of MeCP2, a vertebrate DNA binding protein with affinity for methylated DNA. Nucleic Acids Res 20(19):5085–5092CrossRefPubMedPubMedCentralGoogle Scholar
  27. Montague P, McCallion AS, Davies RW, Griffiths IR (2005) Myelin-associated oligodendrocytic basic protein: a family of abundant CNS myelin proteins in search of a function. Dev Neurosci 28(6):479–487CrossRefGoogle Scholar
  28. Nagarajan RP, Patzel KA, Martin M, Yasui DH, Swanberg SE, Hertz‐Picciotto I, LaSalle JM (2008) MECP2 promoter methylation and X chromosome inactivation in autism. Autism Res 1(3):169–178CrossRefPubMedPubMedCentralGoogle Scholar
  29. Nguyen MVC, Felice CA, Du F, Covey MV, Robinson JK, Mandel G, Ballas N (2013) Oligodendrocyte lineage cells contribute unique features to Rett syndrome neuropathology. J Neurosci 33(48):18764–18774CrossRefPubMedPubMedCentralGoogle Scholar
  30. Paintlia MK, Paintlia AS, Barbosa E, Singh I, Singh AK (2004) N‐acetylcysteine prevents endotoxin‐induced degeneration of oligodendrocyte progenitors and hypomyelination in developing rat brain. J Neurosci Res 78(3):347–361CrossRefPubMedGoogle Scholar
  31. Peirce TR, Bray NJ, Williams NM, Norton N, Owen MJ, Donovan MCO (2006) Convergent Evidence for 2,3 -Cyclic Nucleotide 3 -Phosphodiesterase as a Possible Susceptibility Gene for Schizophrenia. Arch Gen Psychiatry 63(1):18–24CrossRefPubMedGoogle Scholar
  32. Quarles, R. H., Macklin, W. B., & Morell, P. (2006). Biochemistry, 51–72Google Scholar
  33. Saywell V, Viola A, Confort-Gouny S, Le Fur Y, Villard L, Cozzone PJ (2006) Brain magnetic resonance study of Mecp2 deletion effects on anatomy and metabolism. Biochem Biophys Res Commun 340(3):776–783CrossRefPubMedGoogle Scholar
  34. Shahbazian MD, Antalffy B, Armstrong DL, Zoghbi HY (2002) Insight into Rett syndrome: MeCP2 levels display tissue- and cell-specific differences and correlate with neuronal maturation. Hum Mol Genet 11(2):115–124Google Scholar
  35. Swiss VA, Nguyen T, Dugas J, Ibrahim A, Barres B, Androulakis IP, Casaccia P (2011) Identification of a gene regulatory network necessary for the initiation of oligodendrocyte differentiation. PLoS One 6(4), e18088CrossRefPubMedPubMedCentralGoogle Scholar
  36. Tochiki KK, Cunningham J, Hunt SP, Géranton SM (2012) The expression of spinal methyl-CpG-binding protein 2, DNA methyltransferases and histone deacetylases is modulated in persistent pain states. Mol Pain 8:14CrossRefPubMedPubMedCentralGoogle Scholar
  37. Ueno T, Ito J, Hoshikawa S, Ohori Y, Fujiwara S, Yamamoto S, Ogata T (2012) The identification of transcriptional targets of Ascl1 in oligodendrocyte development. Glia 60(10):1495–1505CrossRefPubMedGoogle Scholar
  38. Urdinguio RG, Lopez-Serra L, Lopez-Nieva P, Alaminos M, Diaz-Uriarte R, Fernandez AF, Esteller M (2008) Mecp2-null mice provide new neuronal targets for Rett syndrome. PLoS One 3(11), e3669CrossRefPubMedPubMedCentralGoogle Scholar
  39. Vora P, Mina R, Namaka M, Frost EE (2010) A novel transcriptional regulator of myelin gene expression: implications for neurodevelopmental disorders. Neuroreport 21(14):917–921CrossRefPubMedGoogle Scholar
  40. Wegner M (2008) A matter of identity: transcriptional control in oligodendrocytes. J Mol Neurosci 35(1):3–12CrossRefPubMedGoogle Scholar
  41. Xiao J, Wong AW, Willingham MM, van den Buuse M, Kilpatrick TJ, Murray SS (2010) Brain-derived neurotrophic factor promotes central nervous system myelination via a direct effect upon oligodendrocytes. Neurosignals 18(3):186CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  • Kedarlal Sharma
    • 1
  • Juhi Singh
    • 1
  • Prakash P. Pillai
    • 1
    Email author
  • Emma E. Frost
    • 2
  1. 1.Division of Neurobiology, Department of Zoology, Faculty of ScienceThe M. S. University of BarodaVadodaraIndia
  2. 2.WinnipegCanada

Personalised recommendations